Skip to main content
Top
Published in: Cardiovascular Drugs and Therapy 1/2008

01-02-2008

Effects of Hawthorn on Cardiac Remodeling and Left Ventricular Dysfunction after 1 Month of Pressure Overload-induced Cardiac Hypertrophy in Rats

Authors: Hyun Seok Hwang, Barry E. Bleske, Michael M. J. Ghannam, Kimber Converso, Mark W. Russell, James C. Hunter, Marvin O. Boluyt

Published in: Cardiovascular Drugs and Therapy | Issue 1/2008

Login to get access

Abstract

Purpose

Hawthorn (Crataegus) is a natural product used to treat patients with heart failure. The effects of hawthorn on cardiac remodeling, however, are not known. The purpose was to determine the effects of hawthorn treatment on remodeling and function of the left ventricle (LV) after 1 month of pressure overload-induced cardiac hypertrophy.

Materials and methods

Sprague-Dawley rats (male, 300 g) were subjected to sham operation (SH) or aortic constriction (AC) for 4 weeks and treated with Hawthorn (Crataegus-Extract- WS1442;1.3, 13, 130 mg kg−1 day−1; AC-L, AC-M, AC-H) or vehicle (SH-V, AC-V) for 3 weeks after surgery. Systolic and diastolic function were measured using echocardiographic assessment at baseline and 4 weeks after AC.

Results

AC increased the LV/body weight ratio by 34% in vehicle and hawthorn treated rats. Hawthorn markedly reduced LV chamber volumes (VOL) after AC [systolic VOL, mean ± SEM, mm3: SH-V, 87 ± 13; AC-V, 93 ± 12; AC-L, 62 ± 9; AC-M, 68 ± 12; AC-H; 50 ± 11 and diastolic VOL: SH-V, 433 ± 45; AC-V, 412 ± 57; AC-L, 313 ± 25; AC-M, 319 ± 37; AC-H, 264 ± 25 (p < 0.05)] and augmented relative wall thickness, mm: SH-V, 0.45 ± 0.02; AC-V, 0.65 ± 0.05; AC-L, 0.71 ± 0.03; AC-M, 0.74 ± 0.06; AC-H, 0.80 ± 0.09 (p < 0.05). AC reduced velocity of circumferential shortening (Vcfc) by 28% compared with SH-V. Hawthorn attenuated the AC-induced decrease in Vcfc (p < 0.05).

Conclusions

Hawthorn treatment modifies left ventricular remodeling and counteracts myocardial dysfunction in early pressure overload-induced cardiac hypertrophy.
Literature
1.
go back to reference Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003;65:45–79.PubMedCrossRef Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003;65:45–79.PubMedCrossRef
2.
go back to reference Popping S, Rose H, Ionescu I, Fischer Y, Kammermeier H. Effect of a hawthorn extract on contraction and energy turnover of isolated rat cardiomyocytes. Arzneimittelforschung 1995;45:1157–61.PubMed Popping S, Rose H, Ionescu I, Fischer Y, Kammermeier H. Effect of a hawthorn extract on contraction and energy turnover of isolated rat cardiomyocytes. Arzneimittelforschung 1995;45:1157–61.PubMed
3.
go back to reference Schussler M, Holzl J, Fricke U. Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung 1995;45:842–5.PubMed Schussler M, Holzl J, Fricke U. Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung 1995;45:842–5.PubMed
4.
go back to reference Chang Q, Zhu M, Zuo Z, Chow M, Ho WK. High-performance liquid chromatographic method for simultaneous determination of hawthorn active components in rat plasma. J Chromatogr B Biomed Sci Appl 2001;42:605–12. Chang Q, Zhu M, Zuo Z, Chow M, Ho WK. High-performance liquid chromatographic method for simultaneous determination of hawthorn active components in rat plasma. J Chromatogr B Biomed Sci Appl 2001;42:605–12.
5.
go back to reference Pittler MH, Schmidt K, Ernst E. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med 2003;114:665–74.PubMedCrossRef Pittler MH, Schmidt K, Ernst E. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med 2003;114:665–74.PubMedCrossRef
6.
go back to reference Rietbrock N, Hamel M, Hempel B, Mitrovic V, Schmidt T, Wolf GK. Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure. Arzneimittel-Forschung 2001;51:793–8.PubMed Rietbrock N, Hamel M, Hempel B, Mitrovic V, Schmidt T, Wolf GK. Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure. Arzneimittel-Forschung 2001;51:793–8.PubMed
7.
go back to reference Tauchert M, Gildor A, Lipinski J. High dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure. Herz 1999;24:465–74.PubMed Tauchert M, Gildor A, Lipinski J. High dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure. Herz 1999;24:465–74.PubMed
8.
go back to reference Tauchert M. Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure. Am Heart J 2002;143:910–5.PubMedCrossRef Tauchert M. Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure. Am Heart J 2002;143:910–5.PubMedCrossRef
9.
go back to reference Veveris M, Koch E, Chatterjee SS. Crataegus special extract WS 1442 improves cardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion. Life Sci 2004;74:1945–55.PubMedCrossRef Veveris M, Koch E, Chatterjee SS. Crataegus special extract WS 1442 improves cardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion. Life Sci 2004;74:1945–55.PubMedCrossRef
10.
go back to reference Boluyt MO, Opiteck JA, Devor ST, White TP. Age effects on the adaptive response of the female rat heart following aortic constriction. J Gerontol A Biol Sci Med Sci 2000;55A:B307–314. Boluyt MO, Opiteck JA, Devor ST, White TP. Age effects on the adaptive response of the female rat heart following aortic constriction. J Gerontol A Biol Sci Med Sci 2000;55A:B307–314.
11.
go back to reference Boluyt MO, Li ZB, Loyd AM, Scalia AF, Cirrincione GM, Jackson RR. The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo. Cardiovasc Drugs Ther 2004a;18:257–67.PubMedCrossRef Boluyt MO, Li ZB, Loyd AM, Scalia AF, Cirrincione GM, Jackson RR. The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo. Cardiovasc Drugs Ther 2004a;18:257–67.PubMedCrossRef
12.
go back to reference Boluyt MO, Converso K, Hwang HS, Mikkor A, Russell MW. Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart. J Appl Physiol 2004b;96:822–8.PubMedCrossRef Boluyt MO, Converso K, Hwang HS, Mikkor A, Russell MW. Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart. J Appl Physiol 2004b;96:822–8.PubMedCrossRef
13.
go back to reference Boluyt MO, O'Neill L, Meredith AL, et al. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure: Marked upregulation of genes encoding extracellular matrix proteins. Circ Res 1994;75:23–32.PubMed Boluyt MO, O'Neill L, Meredith AL, et al. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure: Marked upregulation of genes encoding extracellular matrix proteins. Circ Res 1994;75:23–32.PubMed
14.
go back to reference Boluyt MO, Brevick JL, Rogers DS, Randall MJ, Scalia AF, Li ZB. Changes in the rat heart proteome induced by exercise training: Increased abundance of heat shock protein hsp20. Proteomics 2006;10:3154–69.CrossRef Boluyt MO, Brevick JL, Rogers DS, Randall MJ, Scalia AF, Li ZB. Changes in the rat heart proteome induced by exercise training: Increased abundance of heat shock protein hsp20. Proteomics 2006;10:3154–69.CrossRef
15.
go back to reference Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003;107:984–91.PubMedCrossRef Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003;107:984–91.PubMedCrossRef
16.
go back to reference Massion PB, Balligand JL. Relevance of nitric oxide for myocardial remodeling. Current Heart Failure Reports 2007;4:18–25.PubMed Massion PB, Balligand JL. Relevance of nitric oxide for myocardial remodeling. Current Heart Failure Reports 2007;4:18–25.PubMed
17.
go back to reference Zhang M, Shah AM. Role of reactive oxygen species in myocardial remodeling. Current Heart Failure Reports 2007;4:26–30.PubMedCrossRef Zhang M, Shah AM. Role of reactive oxygen species in myocardial remodeling. Current Heart Failure Reports 2007;4:26–30.PubMedCrossRef
18.
go back to reference Dorn GW, Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 2005;115:527–37.PubMedCrossRef Dorn GW, Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 2005;115:527–37.PubMedCrossRef
19.
go back to reference Hilfiker-Kleiner D, Landmesser U, Drexler H. Molecular mechanisms in heart failure. Focus on cardiac hypertrophy, inflammation, angiogenesis, and apoptosis. J Am Coll Cardiol 2006;48:A56–66.CrossRef Hilfiker-Kleiner D, Landmesser U, Drexler H. Molecular mechanisms in heart failure. Focus on cardiac hypertrophy, inflammation, angiogenesis, and apoptosis. J Am Coll Cardiol 2006;48:A56–66.CrossRef
20.
go back to reference Bahorun T, Trotin F, Pommery J, Vasseur J, Pinkas M. Antioxidant activities of Crataegus monogyna extracts. Planta Med 1994;60:323–8.PubMedCrossRef Bahorun T, Trotin F, Pommery J, Vasseur J, Pinkas M. Antioxidant activities of Crataegus monogyna extracts. Planta Med 1994;60:323–8.PubMedCrossRef
21.
go back to reference Bahourn T, Aumjaud E, Ramphul H, et al. Phenolic constituents and antioxidant capacities of Crataegus monogyna (Hawthorn) callus extracts. Food 2003;47:191–8. Bahourn T, Aumjaud E, Ramphul H, et al. Phenolic constituents and antioxidant capacities of Crataegus monogyna (Hawthorn) callus extracts. Food 2003;47:191–8.
22.
go back to reference Chu CY, Lee MJ, Liao CL, Lin WL, Yin YF, Tseng TH. Inhibitory effect of hot-water extract from dried fruit of Crataegus pinnatifida on low-density lipoprotein (LDL) oxidation in cell and cell-free systems. J Agric Food Chem 2003;51:7583–8.PubMedCrossRef Chu CY, Lee MJ, Liao CL, Lin WL, Yin YF, Tseng TH. Inhibitory effect of hot-water extract from dried fruit of Crataegus pinnatifida on low-density lipoprotein (LDL) oxidation in cell and cell-free systems. J Agric Food Chem 2003;51:7583–8.PubMedCrossRef
23.
go back to reference Zhang Z, Chang Q, Zhu M, Huang Y, Ho WKK, Chen ZY. Characterization of antioxidants present in hawthorn fruits. J Nutr Biochem 2001;12:144–52.PubMedCrossRef Zhang Z, Chang Q, Zhu M, Huang Y, Ho WKK, Chen ZY. Characterization of antioxidants present in hawthorn fruits. J Nutr Biochem 2001;12:144–52.PubMedCrossRef
24.
go back to reference Jayalakshmi R, Niranjali DS. Cardioprotective effect of tincture of Crataegus on isoproterenol-induced myocardial infarction in rats. J Pharm Pharmacol 2004;56:921–6.PubMedCrossRef Jayalakshmi R, Niranjali DS. Cardioprotective effect of tincture of Crataegus on isoproterenol-induced myocardial infarction in rats. J Pharm Pharmacol 2004;56:921–6.PubMedCrossRef
25.
go back to reference Shanthi R, Parasakthy K, Deepalakshmi PD, Niranjali DS. Protective effect of tincture of Crataegus on oxidative stress in experimental atherosclerosis in rats. J Clin Biochem Nutr 1996;20:211–23. Shanthi R, Parasakthy K, Deepalakshmi PD, Niranjali DS. Protective effect of tincture of Crataegus on oxidative stress in experimental atherosclerosis in rats. J Clin Biochem Nutr 1996;20:211–23.
26.
go back to reference Aucamp J, Gaspar A, Hara Y, Apostolides Z. Inhibition of xanthine oxidase by catechins from tea (Carmellia sinensis). Anticancer Res 1997;17:4381–5.PubMed Aucamp J, Gaspar A, Hara Y, Apostolides Z. Inhibition of xanthine oxidase by catechins from tea (Carmellia sinensis). Anticancer Res 1997;17:4381–5.PubMed
27.
go back to reference Huang SM, Wu CH, Yen GC. Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs. Mol Nutr Food Res 2006;50:1129–39.PubMedCrossRef Huang SM, Wu CH, Yen GC. Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs. Mol Nutr Food Res 2006;50:1129–39.PubMedCrossRef
28.
go back to reference Wang L, Tu YC, Lian TW, Hung JT, Yen JH, Wu MJ. Distinctive antioxidant and anti-inflammatory effects of flavonols. J Agric Food Chem 2006;54:9798–804.PubMedCrossRef Wang L, Tu YC, Lian TW, Hung JT, Yen JH, Wu MJ. Distinctive antioxidant and anti-inflammatory effects of flavonols. J Agric Food Chem 2006;54:9798–804.PubMedCrossRef
29.
go back to reference Sanchez M, Galisteo M, Vera R, et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 2006;24:75–84.PubMedCrossRef Sanchez M, Galisteo M, Vera R, et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 2006;24:75–84.PubMedCrossRef
30.
go back to reference Kim SH, Kang KW, Kim KW, Kim KD. Procyanidins in crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta. Life Sci 2000;67:121–31.PubMedCrossRef Kim SH, Kang KW, Kim KW, Kim KD. Procyanidins in crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta. Life Sci 2000;67:121–31.PubMedCrossRef
31.
go back to reference Chen ZY, Zhang ZS, Kwan KY, Zhu M, Ho WK, Huang Y. Endothelium-dependent relaxation induced by hawthorn extract in rat mesenteric artery. Life Sci 1998;63:1983–91.PubMedCrossRef Chen ZY, Zhang ZS, Kwan KY, Zhu M, Ho WK, Huang Y. Endothelium-dependent relaxation induced by hawthorn extract in rat mesenteric artery. Life Sci 1998;63:1983–91.PubMedCrossRef
32.
go back to reference Steffen Y, Schewe T, Sies H. Epicatechin protects endothelial cells against oxidized LDL and maintains NO synthase. Biochem Biophys Res Commun 2005;331:1277–83.PubMedCrossRef Steffen Y, Schewe T, Sies H. Epicatechin protects endothelial cells against oxidized LDL and maintains NO synthase. Biochem Biophys Res Commun 2005;331:1277–83.PubMedCrossRef
33.
go back to reference Benito S, Lopez D, Saiz MP, et al. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol 2002;135:910–6.PubMedCrossRef Benito S, Lopez D, Saiz MP, et al. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol 2002;135:910–6.PubMedCrossRef
34.
go back to reference Karim M, McCormick K, Kappagoda CT. Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr 2000;130:2105S–8S.PubMed Karim M, McCormick K, Kappagoda CT. Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr 2000;130:2105S–8S.PubMed
35.
go back to reference Schroeter H, Heiss C, Balzer J, et al. (−)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 2006;103:1024–9.PubMedCrossRef Schroeter H, Heiss C, Balzer J, et al. (−)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 2006;103:1024–9.PubMedCrossRef
36.
go back to reference Kao ES, Wang CJ, Lin WL, Yin YF, Wang CP, Tseng TH. Anti-inflammatory potential of flavonoid contents from dried fruit of Crataegus pinnatifida in vitro and in vivo. J Agric Food Chem 2005;53:430–6.PubMedCrossRef Kao ES, Wang CJ, Lin WL, Yin YF, Wang CP, Tseng TH. Anti-inflammatory potential of flavonoid contents from dried fruit of Crataegus pinnatifida in vitro and in vivo. J Agric Food Chem 2005;53:430–6.PubMedCrossRef
37.
go back to reference Garcia-Mediavilla V, Crespo I, Collado PS, et al. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang liver cells. Eur J Pharmacol 2007;557:221–9.PubMedCrossRef Garcia-Mediavilla V, Crespo I, Collado PS, et al. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang liver cells. Eur J Pharmacol 2007;557:221–9.PubMedCrossRef
38.
go back to reference Kim MJ, Ryu GR, Kang JH, et al. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation. Biochem Pharmacol 2004;68:1775–85.PubMedCrossRef Kim MJ, Ryu GR, Kang JH, et al. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation. Biochem Pharmacol 2004;68:1775–85.PubMedCrossRef
39.
go back to reference Williams RJ, Spencer JPE, Rice-Evans C. Flavonoids: Antioxidants or signalling molecules? Free Rad Biomed 2004;36:838–49.CrossRef Williams RJ, Spencer JPE, Rice-Evans C. Flavonoids: Antioxidants or signalling molecules? Free Rad Biomed 2004;36:838–49.CrossRef
40.
go back to reference Stangl V, Dreger H, Stangl K, Lorenz M. Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res 2007;73:348–58.PubMedCrossRef Stangl V, Dreger H, Stangl K, Lorenz M. Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res 2007;73:348–58.PubMedCrossRef
41.
go back to reference Oak MH, Chataigneau M, Keravis T, et al. Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein kinase pathway. Arterioscler Thromb Vasc Biol 2003;23:1001–7.PubMedCrossRef Oak MH, Chataigneau M, Keravis T, et al. Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein kinase pathway. Arterioscler Thromb Vasc Biol 2003;23:1001–7.PubMedCrossRef
42.
go back to reference Petkov E, Nikolov N, Uzunov P. Inhibitory effect of some flavonoids and flavonoid mixtures on cyclic AMP phosphodiesterase activity of rat heart. Planta Med 1981;43:183–6.CrossRef Petkov E, Nikolov N, Uzunov P. Inhibitory effect of some flavonoids and flavonoid mixtures on cyclic AMP phosphodiesterase activity of rat heart. Planta Med 1981;43:183–6.CrossRef
43.
go back to reference Schwinger RH, Pietsch M, Frank K, Brixius K. Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently. J Cardiovasc Pharmacol 2000;35:700–7.PubMedCrossRef Schwinger RH, Pietsch M, Frank K, Brixius K. Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently. J Cardiovasc Pharmacol 2000;35:700–7.PubMedCrossRef
44.
go back to reference Cirrincione GM, Boluyt MO, Hwang HS, Bleske BE. 3-HMG-Coenzyme A reductase inhibition and extracellular matrix gene expression in the pressure-overloaded rat heart. J Cardiovasc Pharmacol 2006;47:521–30.PubMedCrossRef Cirrincione GM, Boluyt MO, Hwang HS, Bleske BE. 3-HMG-Coenzyme A reductase inhibition and extracellular matrix gene expression in the pressure-overloaded rat heart. J Cardiovasc Pharmacol 2006;47:521–30.PubMedCrossRef
45.
go back to reference McMullen JR, Sherwood MC, Tarnavski O, et al. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 200422;109:3050–5.CrossRef McMullen JR, Sherwood MC, Tarnavski O, et al. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 200422;109:3050–5.CrossRef
46.
go back to reference Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol 1992;262:H1861–1866.PubMed Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol 1992;262:H1861–1866.PubMed
47.
go back to reference Laurent GJ. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 1987;252:C1–9.PubMed Laurent GJ. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 1987;252:C1–9.PubMed
48.
go back to reference Eghbali M, Weber KT. Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression. Mol Cell Biochem 1990;96:1–14.PubMedCrossRef Eghbali M, Weber KT. Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression. Mol Cell Biochem 1990;96:1–14.PubMedCrossRef
49.
go back to reference Cleutjens JP, Kandala JC, Guarda E, Guntaka RV, Weber KT. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 1995;27:1281–92.PubMedCrossRef Cleutjens JP, Kandala JC, Guarda E, Guntaka RV, Weber KT. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 1995;27:1281–92.PubMedCrossRef
50.
go back to reference Aaronson K. HERB-CHF (Hawthorn Extract Randomized Blinded Chronic HF Study). Late-Breaking and Recent Clinical Trials. Presented at the 8th Annual Scientific Meeting of the Heart Failure Society of America; September 12–15, 2004, Toronto, Ontario, Canada. (Abstract). Aaronson K. HERB-CHF (Hawthorn Extract Randomized Blinded Chronic HF Study). Late-Breaking and Recent Clinical Trials. Presented at the 8th Annual Scientific Meeting of the Heart Failure Society of America; September 12–15, 2004, Toronto, Ontario, Canada. (Abstract).
51.
go back to reference Holubarsch CJF, Colucci WS, Meinertz T, et al. Crataegus extract WS 1442 postpones cardiac death in patients with congestive heart failure class NYHA II–III: a randomized, placebo-controlled, double-blind trial in 2681 patients. American College of Cardiology 2007 Scientific Sessions March 27, 2007; New Orleans, LA. Late breaking clinical trials-3, Session 414–5. (Abstract) Holubarsch CJF, Colucci WS, Meinertz T, et al. Crataegus extract WS 1442 postpones cardiac death in patients with congestive heart failure class NYHA II–III: a randomized, placebo-controlled, double-blind trial in 2681 patients. American College of Cardiology 2007 Scientific Sessions March 27, 2007; New Orleans, LA. Late breaking clinical trials-3, Session 414–5. (Abstract)
Metadata
Title
Effects of Hawthorn on Cardiac Remodeling and Left Ventricular Dysfunction after 1 Month of Pressure Overload-induced Cardiac Hypertrophy in Rats
Authors
Hyun Seok Hwang
Barry E. Bleske
Michael M. J. Ghannam
Kimber Converso
Mark W. Russell
James C. Hunter
Marvin O. Boluyt
Publication date
01-02-2008
Publisher
Springer US
Published in
Cardiovascular Drugs and Therapy / Issue 1/2008
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-008-6082-2

Other articles of this Issue 1/2008

Cardiovascular Drugs and Therapy 1/2008 Go to the issue